HUP0103669A3 - Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same - Google Patents

Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same

Info

Publication number
HUP0103669A3
HUP0103669A3 HU0103669A HUP0103669A HUP0103669A3 HU P0103669 A3 HUP0103669 A3 HU P0103669A3 HU 0103669 A HU0103669 A HU 0103669A HU P0103669 A HUP0103669 A HU P0103669A HU P0103669 A3 HUP0103669 A3 HU P0103669A3
Authority
HU
Hungary
Prior art keywords
preparing
same
pharmaceutical preparations
release pharmaceutical
multiple unit
Prior art date
Application number
HU0103669A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HUP0103669A2 publication Critical patent/HUP0103669A2/hu
Publication of HUP0103669A3 publication Critical patent/HUP0103669A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nonmetallic Welding Materials (AREA)
  • General Preparation And Processing Of Foods (AREA)
HU0103669A 1998-09-18 1999-09-17 Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same HUP0103669A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19842753A DE19842753A1 (de) 1998-09-18 1998-09-18 Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
PCT/EP1999/006882 WO2000016748A1 (de) 1998-09-18 1999-09-17 Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
HUP0103669A2 HUP0103669A2 (hu) 2002-01-28
HUP0103669A3 true HUP0103669A3 (en) 2006-07-28

Family

ID=7881376

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103669A HUP0103669A3 (en) 1998-09-18 1999-09-17 Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same

Country Status (29)

Country Link
US (1) US6805881B1 (hu)
EP (1) EP1113787B1 (hu)
JP (1) JP2002526437A (hu)
KR (1) KR100660072B1 (hu)
CN (1) CN1178650C (hu)
AT (1) ATE260645T1 (hu)
AU (2) AU5861499A (hu)
BG (1) BG105325A (hu)
BR (1) BR9913839A (hu)
CA (1) CA2344372C (hu)
DE (2) DE19842753A1 (hu)
DK (1) DK1113787T3 (hu)
EE (1) EE04700B1 (hu)
ES (1) ES2215404T3 (hu)
HK (1) HK1040932B (hu)
HR (1) HRP20010198A2 (hu)
HU (1) HUP0103669A3 (hu)
ID (1) ID28735A (hu)
IL (2) IL141532A0 (hu)
NO (1) NO20011211L (hu)
NZ (1) NZ510563A (hu)
PL (1) PL195543B1 (hu)
PT (1) PT1113787E (hu)
RU (1) RU2235540C2 (hu)
SK (1) SK285099B6 (hu)
TR (1) TR200100756T2 (hu)
UA (1) UA73097C2 (hu)
WO (2) WO2000016747A1 (hu)
ZA (1) ZA200101485B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
EP1830886B1 (en) 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005012561B4 (de) 2005-03-18 2008-06-19 Christian Beer Verfahren zum Betrieb eines Werkstück-Transfersystems
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
CA2624310C (en) 2005-10-04 2014-01-07 Bayer Healthcare Ag Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
CN100448432C (zh) * 2006-10-26 2009-01-07 徐竹青 高溶出度尼莫地平分散片的制备方法
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
US7952167B2 (en) * 2007-04-27 2011-05-31 Taiwan Semiconductor Manufacturing Company, Ltd. Scribe line layout design
EP2391345B1 (en) * 2009-01-28 2014-09-03 Novartis AG Galenic formulations comprising aliskiren
US20100247646A1 (en) * 2009-03-26 2010-09-30 Ranbaxy Laboratories Limited Extended release tablets of nisoldipine
PL2554168T3 (pl) 2010-03-29 2018-05-30 Astellas Pharma Inc. Kompozycja farmaceutyczna do kontrolowanego uwalniania

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5482525A (en) 1977-12-13 1979-06-30 Aisan Ind Co Ltd Exhaust gas recirculation system
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4449983A (en) 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
DE3612212A1 (de) 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE3720757A1 (de) 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
DE3830353A1 (de) 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
JPH03145418A (ja) 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
AU1537292A (en) 1991-04-16 1992-11-17 Nippon Shinyaku Co. Ltd. Method of manufacturing solid dispersion
DE4138513A1 (de) 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
FR2725624B1 (fr) 1994-10-14 1997-01-17 Jouveinal Inst Rech Procede de preparation de formes pharmaceutiques a liberation controlee
DE19504831A1 (de) 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose

Also Published As

Publication number Publication date
WO2000016748A1 (de) 2000-03-30
ATE260645T1 (de) 2004-03-15
KR100660072B1 (ko) 2006-12-22
EE04700B1 (et) 2006-10-16
NO20011211D0 (no) 2001-03-09
EP1113787B1 (de) 2004-03-03
DE19842753A1 (de) 2000-03-23
WO2000016747A1 (de) 2000-03-30
ID28735A (id) 2001-06-28
CN1178650C (zh) 2004-12-08
CN1317959A (zh) 2001-10-17
IL141532A (en) 2007-03-08
PL346535A1 (en) 2002-02-11
SK285099B6 (sk) 2006-06-01
DK1113787T3 (da) 2004-05-17
AU750617B2 (en) 2002-07-25
HK1040932B (zh) 2005-08-05
AU6191899A (en) 2000-04-10
ZA200101485B (en) 2002-02-22
PT1113787E (pt) 2004-07-30
AU5861499A (en) 2000-04-10
NZ510563A (en) 2002-10-25
RU2235540C2 (ru) 2004-09-10
KR20010073172A (ko) 2001-07-31
BG105325A (bg) 2001-11-30
CA2344372A1 (en) 2000-03-30
DE59908764D1 (de) 2004-04-08
TR200100756T2 (tr) 2001-07-23
ES2215404T3 (es) 2004-10-01
EE200100161A (et) 2002-08-15
JP2002526437A (ja) 2002-08-20
HK1040932A1 (en) 2002-06-28
UA73097C2 (en) 2005-06-15
PL195543B1 (pl) 2007-09-28
CA2344372C (en) 2009-12-22
EP1113787A1 (de) 2001-07-11
US6805881B1 (en) 2004-10-19
IL141532A0 (en) 2002-03-10
HRP20010198A2 (en) 2002-04-30
NO20011211L (no) 2001-03-09
HUP0103669A2 (hu) 2002-01-28
SK3722001A3 (en) 2001-10-08
BR9913839A (pt) 2001-06-12

Similar Documents

Publication Publication Date Title
HUP0103669A3 (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
GR970300037T1 (en) Phenol-derivatives having pharmaceutical activity and process for preparing the same
GB9900156D0 (en) Erythromycins and process for the preparation
HRP950217B1 (en) Novel erythromycin derivatives, method for preparing the same and use thereof as drugs
HUP0100347A3 (en) Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparation
IL125622A0 (en) Novel erythromycin derivatives method for preparing same and use thereof as drugs
HK1026710A1 (en) Food grade wax and process for preparing same
ZA978053B (en) Frozen product and process for the preparation thereof
EP1450716A4 (en) METHOD AND SYSTEMS FOR THE PRODUCTION OF BLOOD PRECAUTIONS
AU5761299A (en) Highly pure polystyrene, method for preparing the same and disposable food container using the same
ZA200201057B (en) Radiopharmaceutical products and their preparation procedure.
HRP980258B1 (en) New triazole derivatives, process for the preparation thereof and pharmaceutical preparations containing them
EP0990632A4 (en) ADAMANTANEMETHANOL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
EP0890599A4 (en) POLYORGANOSILOXANES AND METHOD FOR THE PRODUCTION THEREOF
IL120554A0 (en) Kombucha products and processes for the preparation thereof
AU2001274740A1 (en) High density products and method for the preparation thereof
IL128182A0 (en) Novel erythromycin derivatives method for preparing same and use thereof as drugs
IL130420A (en) Erythromycin derivatives, method for preparing them and their use as medicine
GR3035834T3 (en) Benzoxazindione derivatives, process for their preparation and their use
SI1113787T1 (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
HUP0103569A3 (en) New medicament and process for its preparation
HU0002717D0 (en) 13-deoxyanthracycline derivatives and processes for preparing them
AU6449500A (en) Method for obtaining health-promoting products and resulting products
AU3142499A (en) Device and method for preparing food portions
EP1089709A4 (en) ICE CREAM-LIKE PHARMACEUTICAL FORMULATION AND METHOD FOR PRODUCING THE SAME

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees